T1	Participants 86 142	intermediate-grade and high-grade non-Hodgkin's lymphoma
T2	Participants 172 196	a study of 464 patients.
T3	Participants 834 916	Patients were younger than 55 years and had at least one adverse prognostic factor
T4	Participants 1158 1214	464 patients were assessable for the consolidation phase
